deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02107131

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab (ERASER)

Evaluation of ReAding Speed, Contrast Sensitivity, and Work Productivity in Working Individuals With Diabetic Macular Edema Following Treatment With Intravitreal Ranibizumab

Sponsor: California Retina Consultants

Conditions Diabetic Macular Edema
Interventions Intravitreal ranibizumab 0.3mg
Updated 9 times since 2017 Last updated: Nov 30, 2018 Started: Mar 13, 2015 Primary completion: May 15, 2017 Completion: May 15, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Diabetic Macular Edema and is currently completed. California Retina Consultants leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshotActive Not Recruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotCompleted~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshotCompleted~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Phase: PHASE2_PHASE3 → PHASE4

  5. Aug 2018 — Jan 2019 [monthly]

    Completed PHASE2_PHASE3

▶ Show 4 earlier versions

  1. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE2_PHASE3

  2. Feb 2018 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    Status: Active Not Recruiting → Completed

  3. Feb 2017 — Feb 2018 [monthly]

    Active Not Recruiting PHASE2_PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • California Retina Consultants
Data source: California Retina Consultants

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations